Vaxdyn awarded €14.5 Million from the EIC Accelerator to Fund the Clinical Phase of Its Va... 02/09/2024 Healthcare Access to innovation Innovative drugs Antibiotic resistance The European Commission is committed to combating antibiotic resistance through vaccines, selecting Vaxdyn's competitive... Partners - Vaxdyn
European researchers combine physics and biology to develop new biosensors 03/09/2024 Healthcare Access to innovation The result will be an ultra-sensitive biosensor based on DNA origami. Partners - TECNALIA
IDiBE obtains the renewal of its Scientific Unit for Business Innovation by IVACE+I 26/08/2024 Healthcare Access to innovation Partners - IDiBE – UMH (Instituto de Investigación, Desarrollo e innovación en Biotecnología Sanitaria)
Peaches Biotech ready to enter into the production of biological medicines with the Histok... 06/08/2024 Healthcare Access to innovation Innovative drugs Advanced therapies The Madrid-based laboratory, together with Histocell and Cardiva, has launched Histokine, located in the Basque Country... Partners - PEACHES BIOTECH S.L.
ORYZON reports financial results and corporate update for half-year ending June 30, 2024 01/08/2024 Healthcare Access to innovation Innovative drugs Advanced therapies Research and development (R&D) expenses of $4.9m for the half-year ending June 30, 2024. As a result of the completion... Partners - Oryzon Genomics
What is Open Innovation in pharmaceutical R&D? 18/07/2024 Healthcare Access to innovation Drug discovery Innovative drugs The core idea of Open innovation is that companies leverage the ideas and resources of external actors such as customers... Partners - GENESIS Biomed
Integra Therapeutics to receive up to €10.5 million from European Commission for its FiCAT... 17/07/2024 Healthcare Access to innovation Rare diseases Advanced therapies EU projects This funding will enable Integra Therapeutics to launch its first gene therapy to treat a serious pediatric hepatic... Partners - Integra Therapeutics S.L.
It’s “All-go” with Oligos: Challenges and Opportunities in LC-MS of Therapeutic 17/07/2024 Healthcare Access to innovation The episode will focus on oligonucleotide LC-MS, covering key challenges, the critical importance of assay sensitivity... Partners
AseBio values the call for grants aimed at the development of UiC positively but regrets t... 16/07/2024 Healthcare Access to innovation Financing We trust that the call will strengthen the country's clinical research capabilities, which will help consolidate Spain's... AseBio
The Teófilo Hernando Foundation (FTH), CRO in Spain and Portugal, supports a clinical stud... 05/07/2024 Healthcare Access to innovation The participation of two of the participating sites in Spain, Hospital Universitario de Toledo and Hospital... Partners - Fundación Teófilo Hernando (FTH)
